Tristel PLC Director Appointment (0430P)
February 05 2019 - 2:01AM
UK Regulatory
TIDMTSTL
RNS Number : 0430P
Tristel PLC
05 February 2019
Tristel plc
("Tristel" or the "Company")
Director Appointment
Tristel plc (AIM: TSTL), the manufacturer of infection
prevention and contamination control products utilising proprietary
chlorine dioxide chemistry, announces the appointment of Dr. Bruno
Holthof to its Board as a non-executive director.
Dr. Bruno Holthof is the Chief Executive Officer of Oxford
University Hospitals ("OUH"). Before OUH, he was CEO of the Antwerp
Hospital Network from January 2004 until September 2015. Bruno
Holthof is also Chair of the Board of Armonea, a European private
care home provider.
Before becoming a CEO, he was a partner at McKinsey &
Company. During this period, he served a wide range of healthcare
clients in Europe and the United States and gained significant
expertise in the areas of strategy, organisation and operations. He
holds an MBA from the Harvard Business School and an MD/PhD from
the University of Leuven.
Commenting on the appointment, Paul Swinney, CEO of Tristel,
said: "We are delighted to welcome Bruno to our Board. Bruno has
more than 10 years of board level experience on publicly listed
companies. He also brings to the Board an in-depth knowledge and
operational experience of healthcare systems in different markets.
We very much look forward to working together."
For further information please contact:
Tristel plc Tel: 01638 721 500
Paul Swinney, Chief Executive
Officer
Liz Dixon, Finance Director
Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
finnCap Tel: 020 7220 0500
Geoff Nash/ Giles Rolls (Corporate
Finance)
Alice Lane (Corporate Broking)
Regulatory disclosure - The following information is disclosed
in accordance with Rule 17 and paragraph (g) of Schedule 2 of the
AIM Rules for Companies.
Bruno Luc Myriam Holthof, 57, holds nil ordinary shares in the
Company and nil options. Dr. Holthof current and previous
directorships are as follows:
Current Directorships/Partnerships:
Project Tower Member 2 Limited
Praksis UK Ltd
Shelford Health Roundtable
Oxford University Hospital NHS Foundation Trust
Armonea Group NV
Directorship held in last 5 years:
Barco NV
BPost NV/SA
Save for the disclosures above, there are no further disclosures
to be made in accordance with Rule 17 and Schedule 2(g) of the AIM
Rules.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAUSSKRKBAURAR
(END) Dow Jones Newswires
February 05, 2019 02:01 ET (07:01 GMT)
Tristel (LSE:TSTL)
Historical Stock Chart
From Apr 2024 to May 2024
Tristel (LSE:TSTL)
Historical Stock Chart
From May 2023 to May 2024